Neumora Therapeutics
NMRA
#9833
Rank
C$0.13 B
Marketcap
C$0.69
Share price
34.99%
Change (1 day)
-83.59%
Change (1 year)

Quarterly Reports (10-Q)

Latest form 10-Q quarterly reports for Neumora Therapeutics CIK: 0001885522

Thumbnail Neumora Therapeutics 10-Q Quarterly Report FY2026 Q2

10-Q Quarterly Report FY2026 Q2

Language: English

Quarterly Reports (10-Q)
Thumbnail Neumora Therapeutics 10-Q Quarterly Report FY2026 Q1

10-Q Quarterly Report FY2026 Q1

Language: English

Quarterly Reports (10-Q)
Thumbnail Neumora Therapeutics 10-Q Quarterly Report FY2025 Q3

10-Q Quarterly Report FY2025 Q3

Language: English

Quarterly Reports (10-Q)
Thumbnail Neumora Therapeutics 10-Q Quarterly Report FY2025 Q2

10-Q Quarterly Report FY2025 Q2

Language: English

Quarterly Reports (10-Q)
Thumbnail Neumora Therapeutics 10-Q Quarterly Report FY2025 Q1

10-Q Quarterly Report FY2025 Q1

Language: English

Quarterly Reports (10-Q)
Thumbnail Neumora Therapeutics 10-Q Quarterly Report FY2024 Q3

10-Q Quarterly Report FY2024 Q3

Language: English

Quarterly Reports (10-Q)
Thumbnail Neumora Therapeutics 10-Q Quarterly Report FY2024 Q2

10-Q Quarterly Report FY2024 Q2

Language: English

Quarterly Reports (10-Q)
Thumbnail Neumora Therapeutics 10-Q Quarterly Report FY2024 Q1

10-Q Quarterly Report FY2024 Q1

Language: English

Quarterly Reports (10-Q)
Thumbnail Neumora Therapeutics 10-Q Quarterly Report FY2023 Q3

10-Q Quarterly Report FY2023 Q3

Language: English

Quarterly Reports (10-Q)